Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine — Indianapolis, Indiana

Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Primary Open Angle Glaucoma.

Sponsors: Visior Technologies Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine?

Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine conducted?

Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine has 1 clinical trials on record. Their work covers Primary Open Angle Glaucoma.

Is Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine accredited by Crixeo Health?

Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.